Vor Biopharma Inc.

NasdaqGS:VOR 株式レポート

時価総額：US$54.3m

Vor Biopharma マネジメント

マネジメント 基準チェック /34

Vor Biopharmaの CEO はRobert Angで、 Aug2019年に任命され、 の在任期間は 5.25年です。 の年間総報酬は$ 2.69Mで、 22.5%給与と77.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.86%を直接所有しており、その価値は$ 468.62K 。経営陣と取締役会の平均在任期間はそれぞれ2.1年と4.3年です。

主要情報

Robert Ang

最高経営責任者

US$2.7m

報酬総額

CEO給与比率22.5%
CEO在任期間5.3yrs
CEOの所有権0.9%
経営陣の平均在職期間2.1yrs
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

Vor Biopharma (NASDAQ:VOR) Will Have To Spend Its Cash Wisely

Sep 10
Vor Biopharma (NASDAQ:VOR) Will Have To Spend Its Cash Wisely

We're A Little Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate

May 24
We're A Little Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate

Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation

Dec 05
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation

Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?

Aug 18
Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?

Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans

May 05
Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans

Is Vor Biopharma Inc. (NASDAQ:VOR) Trading At A 49% Discount?

Mar 13
Is Vor Biopharma Inc. (NASDAQ:VOR) Trading At A 49% Discount?

We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully

Oct 19
We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully

Vor Bio appoints Eyal C. Attar as chief medical officer

Oct 12

Is Vor Biopharma (NASDAQ:VOR) In A Good Position To Invest In Growth?

Jun 18
Is Vor Biopharma (NASDAQ:VOR) In A Good Position To Invest In Growth?

Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans

Mar 05
Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans

Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans

Aug 30
Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans

Vor Biopharma: Targeted Therapies For Transplants

Jun 30

We're Not Very Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate

May 10
We're Not Very Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate

Vor Biopharma EPS misses by $0.03

May 06

CEO報酬分析

Vor Biopharma の収益と比較して、Robert Ang の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$112m

Jun 30 2024n/an/a

-US$118m

Mar 31 2024n/an/a

-US$120m

Dec 31 2023US$3mUS$606k

-US$118m

Sep 30 2023n/an/a

-US$116m

Jun 30 2023n/an/a

-US$106m

Mar 31 2023n/an/a

-US$98m

Dec 31 2022US$5mUS$570k

-US$92m

Sep 30 2022n/an/a

-US$86m

Jun 30 2022n/an/a

-US$81m

Mar 31 2022n/an/a

-US$78m

Dec 31 2021US$2mUS$508k

-US$70m

Sep 30 2021n/an/a

-US$70m

Jun 30 2021n/an/a

-US$65m

Mar 31 2021n/an/a

-US$56m

Dec 31 2020US$3mUS$424k

-US$49m

報酬と市場: Robertの 総報酬 ($USD 2.69M ) は、 US市場 ($USD 649.63K ) の同規模の企業の平均を上回っています。

報酬と収益: Robertの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Robert Ang (49 yo)

5.3yrs

在職期間

US$2,691,044

報酬

Dr. Robert Ang, MBBS, MBA, M.D., serves as Independent Non-Executive Director at Enara Bio Limited since September 2021 and serves as its Chairman since August 2024. He is the President, Chief Executive Of...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Robert Ang
President5.3yrsUS$2.69m0.86%
$ 468.6k
Tirtha Chakraborty
Chief Scientific Officer4yrsUS$1.31m0.14%
$ 78.5k
Eyal Attar
Chief Medical Officer2.1yrsUS$1.40m0.015%
$ 8.2k
Siddhartha Mukherjee
Scientific Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
Han Choi
Chief Financial Officerless than a yearデータなしデータなし
Amy Quinlan
Interim Principal Accounting Officerless than a yearデータなし0.042%
$ 22.7k
Tania Philipp
Chief People Officer4.9yrsデータなしデータなし
John King
Chief Commercial Officer & Head of Business Development4.3yrsデータなしデータなし
Samir Vattompadam
Senior Vice President of Portfolio Strategy & Program Management1.1yrsデータなしデータなし
David Phillips
Senior VP & Head of Quality1.1yrsデータなしデータなし

2.1yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: VORの経営陣は 経験豊富 であると考えられます ( 2.1年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Robert Ang
President5.3yrsUS$2.69m0.86%
$ 468.6k
Siddhartha Mukherjee
Scientific Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
David Lubner
Independent Director4.3yrsUS$151.60k0%
$ 0
Matthew Patterson
Independent Chairman of the Board4.1yrsUS$185.60k0.0088%
$ 4.8k
Joshua Resnick
Independent Director5.8yrsUS$157.50k0%
$ 0
Eric Sievers
Scientific & Clinical Advisorno dataデータなしデータなし
Sven Lundberg
Independent Director5.7yrsUS$152.10k0.043%
$ 23.3k
Daniella Beckman
Independent Director4.3yrsUS$164.10kデータなし
Steven Devine
Scientific & Clinical Advisorno dataデータなしデータなし
Robert Soiffer
Scientific & Clinical Advisorno dataデータなしデータなし
Hans-Peter Kiem
Scientific & Clinical Advisorno dataデータなしデータなし
Soheil Meshinchi
Scientific & Clinical Advisor3.8yrsデータなしデータなし

4.3yrs

平均在職期間

53yo

平均年齢

経験豊富なボード: VORの 取締役会 は 経験豊富 であると考えられます ( 4.3年の平均在任期間)。